Human amniotic membrane as an alternative source of stem cells for regenerative medicine

Differentiation

Volumn 81, Issue 3, 2011, Pages 162-171

  Díaz Prado, Silvia ^a,b   Muiños López, Emma ^a   Hermida Gómez, Tamara ^a   Cicione, Claudia ^a,b   Rendal Vázquez, M Esther ^a   Fuentes Boquete, Isaac ^a,b   de Toro, Francisco J ^a,b   Blanco, Francisco J ^a,b  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Amnion derived cells; Amniotic membrane; Cartilage; Differentiation pluripotent; Mesenchymal stem cell; Osteoarthritis

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA6 INTEGRIN; BETA INTEGRIN; BETA1 INTEGRIN; BREAST CANCER RESISTANCE PROTEIN; CD11 ANTIGEN; CD24 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD9 ANTIGEN; DESMIN; ENDOGLIN; HERMES ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; REX PROTEIN; SCATTER FACTOR RECEPTOR; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TUMOR REJECTION ANTIGEN; UVOMORULIN; VIMENTIN;

ADIPOCYTE; AMNION CELL; AMNIOTIC MEMBRANE STEM CELL; ANTIINFLAMMATORY ACTIVITY; CARTILAGE CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL POPULATION; CELL THERAPY; CELL TYPE; ECTODERM; ENDOTHELIUM CELL; HEART MUSCLE CELL; HUMAN; IMMUNOGENICITY; IMMUNOPHENOTYPING; IN VITRO STUDY; LIVER CELL; MESENCHYME CELL; MESODERM; MUSCLE CELL; NERVE CELL; OSTEOCYTE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL;

AMNION; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; MESENCHYMAL STEM CELLS; REGENERATIVE MEDICINE; STEM CELLS; TISSUE THERAPY;

EID: 79952617738     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2011.01.005     Document Type: Review

References (124)

1. Abdallah BM, Haack-Sorensen M, Burns JS, Elsnab B, Jakob F, Hokland P, Kassem M. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem. Biophys. Res. Commun. 2005, 326:527-538.
2. Alsalameh S, Amin R, Gemba T, Lotz M. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum. 2004, 50:1522-1532.
3. Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, Lanzoni G, Cantoni S, Cavallini C, Bianchi F, Tazzari PL, Pasquinelli G, Foroni L, Ventura C, Grossi A, Bagnara GP. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with ability to differentiate into endothelial cells in vitro. BMC Dev. Biol. 2007, 7:11.
4. Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, Lombardi G, Arienti D, Calamani F, Zatti D, Paul P, Albertini A, Zorzi F, Cavagnini A, Candotti F, Wengler GS, Parolini O. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 2004, 78:1439-1448.
5. Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007, 25:1384-1392.
6. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp. Hematol. 2000, 28:707-715.
7. Barlow S, Brooke G, Chatterjee K, Price G, Pelekanos R, Rossetti T, Doody M, Venter D, Pain S, Gilshenan K, Atkinson K. Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev. 2008, 17:1095-1108.
8. Bianco P, Robey PG. Stem cells in tissue engineering. Nature 2001, 414:118-121.
9. Bilic G, Zeisberger SM, Mallik AS, Zimmermann R, Zisch AH. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant 2008, 17:955-968.
10. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 2006, 7:14-20.
11. Brandt KD, Mazzuca SA. Experience with a placebo-controlled randomized clinical trial of a disease-modifying drug for osteoarthritis: the doxycycline trial. Rheum. Dis. Clin. North Am. 2006, 32:217-234.
12. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. 1994, 331:889-895.
13. Brooks PM. Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Curr. Opin. Rheumatol. 2002, 14:573-577.
14. Caplan AI. Mesenchymal stem cells. J. Orthop. Res. 1991, 9:641-650.
15. Chang Y-J, Hwang S-M, Tseng C-P, Cheng F-C, Huang S-H, Hsu L-F, Hsu L-W, Tsai M-S. Isolation of mesenchymal stem cells with neurogenic potential from the mesoderm of the amniotic membrane. Cells Tissues Organs 2010, 192:93-105.
16. Davila JC, Cezar GG, Thiede M, Strom S, Miki T, Trosko J. Use and application of stem cells in toxicology. Toxicol. Sci. 2004, 79:214-223.
17. Dazzi F, Marelli-Berg F. Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells. Eur. J. Immunol. 2008, 38:1479-1482.
18. De Bari C, Dell'Acio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001, 44:1928-1942.
19. Díaz-Prado S, Muíños-López E, Hermida-Gómez T, Rendal-Vázquez ME, Fuentes-Boquete I, de Toro FJ, Blanco FJ Isolation and characterization of mesenchymal stem cells from human amniotic membrane. Tissue Eng. Part C Methods 2010, 1. August.
20. Díaz-Prado S, Muíños-López E, Hermida-Gómez T, Rendal-Vázquez ME, Fuentes-Boquete I, de Toro FJ, Blanco FJ Multilineage differentiation potential of cells isolated from the human amniotic membrane. J. Cell Biochem. 2010, 111:846-857.
21. Díaz-Prado S, Rendal-Vázquez ME, Muíños López E, Hermida-Gómez T, Rodríguez-Cabarcos M, Fuentes-Boquete I, de Toro FJ, Blanco FJ Potential use of the human amniotic membrane as a scaffold in human articular cartilage repair. Cell Tissue Bank 2010, 11:183-195.
22. Djouad F, Bony C, Häupl T, Uzé G, Lahlou N, Louis-Plence P, Apparailly F, Canovas F, Réme T, Sany J, Jorgensen C, Noël D. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal cells. Arthritis Res. Ther. 2005, 7:1304-1315.
23. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Dj Prockop, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 2006, 8:315-317.
24. Dounchis JS, Goomer RS, Harwood FL, Khatod M, Coutts RD, Amiel D. Chondrogenic phenotype of perichondrium-derived chondroprogenitor cells is influenced by transforming growth factor-beta 1. J. Orthop. Res. 1997, 15:803-807.
25. Dua H.S., Gomes J.A., King A.J., Maharajan V.S. The amniotic membrane in ophthalmology. Surv. Ophthalmol. 2004, 49:51-77.
26. Elwan MA, Sakuragawa N. Evidence for synthesis and release of catecholamines by human amniotic epithelial cells. Neuroreport 1997, 8:3435-3438.
27. Fauza D. Amniotic fluid and placental stem cells. Best Pract. Res. Clin. Obstet. Gynaecol. 2004, 18:877-891.
28. Fickert S, Fiedler J, Brenner RE. Identification, quantification and isolation of mesenchymal progenitor cells from osteoarthritic synovium by fluorescence automated cell sorting. Osteoarthritis Cartilage 2003, 11:790-800.
29. Fuentes-Boquete IM, Arufe Gonda MC, Díaz Prado S, Hermida Gómez T, de Toro Santos FJ, Blanco García FJ Tratamiento de lesiones del cartílago articular con terapia celular. Reumatol. Clin. 2007, 3:S63-S69. 3 Suppl.
30. Fuentes-Boquete IM, Arufe Gonda MC, Díaz Prado SM, Hermida Gómez T, de Toro santos FJ, Blanco FJ Cell and tissue transplant strategies for joint lesions. Open Transplantation J. 2008, 2:21-28.
31. Ganatra M.A. Amniotic membrane in surgery. J. Pak. Med. Assoc. 2003, 53:29-32.
32. Gomes J.A., Romano A., Santos M.S., Dua H.S. Amniotic membrane use in ophthalmology. Curr. Opin. Ophthalmol. 2005, 16:233-240.
33. Han EH, Bae WC, Hsieh-Bonassera ND, Wong VW, Schumacher BL, Görtz S, Masuda K, Bugbee WD, Sah RL. Shaped, stratified, scaffold-free grafts for articular cartilage defects. Clin. Orthop. Relat. Res. 2008, 466:1912-1920.
34. Hao Y., Ma D.H., Hwang D.G., Kim W.S., Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 2000, 19:348-352.
35. Hennerbichler S, Reichl B, Pleiner D, Gabriel C, Eibl J, Redl H. The influence of various storage conditions on cell viability in amniotic membrane. Cell Tissue Bank 2007, 8:1-8.
36. Hombach-Klonisch S, Panigrahi S, Rashedi I, Seifert A, Alberti E, Pocar P, Kurpisz M, Schulze-Osthoff K, Mackiewicz A, Los M. Adult stem cells and their trans-differentiation potential-perspectives and therapeutic applications. J. Mol. Med. 2008, 86:1301-1314.
37. Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol. Reprod. 2007, 77:577-588.
38. Ilancheran S, Moodley Y, Manuelpillai U. Human fetal membranes: a source of stem cells for tissue regeneration and repair?. Placenta 2009, 30:2-10.
39. Im GI, Kim DY, Shin JH, Hyun CW, Cho WH. Repair of cartilage defect in the rabbit with cultured mesenchymal stem cells from bone marrow. J. Bone Joint Surg. Br. 2001, 83:289-294.
40. Insausti CL, Blanquer M, Bleda P, Iniesta P, Majado MJ, Castellanos G, Moraleda JM. The amniotic membrane as a source of stem cells. Histol. Histopathol. 2010, 25:91-98.
41. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, Kanhai HH Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004, 22:1338-1345.
42. In't Anker PS, Noort WA, Kruisselbrink AB, Scherjon SA, Beekhuizen W, Willemze R, Kanhai HH, Fibbe WE. Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp. Hematol. 2003, 31:881-889.
43. Ishiguro N, Kojima T, Poole R. Mechanism of cartilage destruction in osteoarthritis. Nagoya J. Med. Sci. 2002, 65:73-84.
44. Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble JM, Bunnell BA. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J. Cell Biochem. 2006, 99:1285-1297.
45. Jin CZ, Park SR, Choi BH, Lee KY, Kang CK, Min BH. Human amniotic membrane as a delivery matrix for articular cartilage repair. Tissue Eng. 2007, 13:693-702.
46. Jung DI, Ha J, Kang BT, Kim JW, Quan FS, Lee JH, Woo EJ, Park HM. A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury. J. Neurol. Sci. 2009, 285:67-77.
47. Kakishita K, Elwan MA, Nakao N, Itakura T, Sakuragawa N. Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: a potential source of donor for transplantation therapy. Exp. Neurol. 2000, 165:27-34.
48. Kakishita K, Nakao N, Sakuragawa N, Itakura T. Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopaminen lesions. Brain Res. 2003, 980:48-56.
49. Kastrinaki M-C, Andreakou I, Charbord P, Papadaki HA. Isolation of human bone marrow mesenchymal stem cells using different membrane markers: comparison of colony/cloning efficiency, differentiation potential, and molecular profile. Tissue Eng. Part C Methods 2008, 14:333-339.
50. Kim J, Kang HM, Kim H, Kim MR, Kwon HC, Gye MC, Kang SG, Yang HS, You J. Ex vivo characteristics of human amniotic membrane-derived stem cells. Cloning Stem Cells 2007, 9:581-594.
51. Kim SS, Song CK, Shon SK, Lee KY, Kim CH, Lee MJ, Wang L. Effects of human amniotic membrane grafts combined with marrow mesenchymal stem cells on healing of full-thickness skin defects in rabbits. Cell Tissue Res. 2009, 336:59-66.
52. Kobayashi M, Yakuwa T, Sasaki K, Sato K, Kikuchi A, Kamo I, Yokoyama Y, Sakuragawa N. Multilineage potential of side population cells from human amnion mesenchymal layer. Cell Transplant. 2008, 17:291-301.
53. Koga H, Shimaya M, Muneta T, Nimura A, Morito T, Hayashi M, Suzuki S, Ju YJ, Mochizuki T, Sekiya I. Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect. Arthritis Res. Ther. 2008, 10:R84.
54. Kosuga M, Takahashi S, Sasaki K, Enosawa S, Li XK, Okuyama S, Fujino M, Suzuki S, Yamada M, Matsuo N, Sakuragawa N, Okuyama T. Phenotype correction in murine mucopolysaccharidosis type VII by transplantation of human amniotic epithelial cells after adenovirus-mediated gene transfer. Cell Transplant. 2000, 9:687-692.
55. Kuo CK, Li WJ, Mauck RL, Tuan RS. Cartilage tissue engineering: its potential and uses. Curr. Opin. Rheumatol. 2006, 18:64-73.
56. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG. Circulating skeletal stem cells. J. Cell Biol. 2001, 153:1133-1140.
57. Le Blanc K, Götherström C, Ringdén O, Hassan M, McMahon R, Horwitz E, Anneren G, Axelsson O, Nunn J, Ewald U, Nordén Lindeberg S, Jansson M, Dalton A, Aström E, Westgren M. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005, 79:1607-1614.
58. Li W, He H, Chen YT, Hayashida Y, Tseng SC. Reversal of myofibroblasts by amniotic membrane stromal extract. J. Cell Physiol. 2008, 215:657-664.
59. Mankin HJ. The response of articular cartilage to mechanical injury. J. Bone Joint Surg. Am. 1982, 64:460-466.
60. Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica 2001, 86:1099-1100.
61. Matikainen T, Laine J. Placenta-an alternative source of stem cells. Toxicol. Appl. Pharmacol. 2005, 207(2 Suppl.):544-549.
62. McGuckin CP, Forraz N, Baradez MO, Navran S, Zhao J, Urban R, Tilton R, Denner L. Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif. 2005, 38:245-255.
63. Meller D, Pires RT, Mack RJ, Figueiredo F, Heiligenhaus A, Park WC, Prabhasawat P, John T, McLeod SD, Steuhl KP, Tseng SC. Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology 2000, 107:980-989.
64. Mihu CM, Rus Ciucǎ D, Soritǎu O, Suşman S, Mihu D. Isolation and characterization of mesenchymal stem cells from the amniotic membrane. Rom. J. Morphol. Embryol. 2009, 50:73-77.
65. Miki T, Lehmann T, Cai H, Stolz DB, Strom SC. Stem cell characteristics of amniotic epithelial cells. Stem Cells 2005, 23:1549-1559.
66. Miki T, Marongiu F, Ellis E, Strom S. Isolation of amniotic epithelial stem cells. Curr. Protoc. Stem Cell Biol. 2007, 3. 1E.3.1-1E.3.9.
67. Miki T, Mitamura K, Ross MA, Stolz DB, Strom SC. Identification of stem cell marker-positive cells by immunofluorescence in term human amnion. J. Reprod. Immunol. 2007, 75:91-96.
68. Miki T, Strom SC. Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev. 2006, 2:133-142.
69. Minas T, Chiu R. Autologous chondrocyte implantation. Am. J. Knee Surg. 2000, 13:41-50.
70. Minguell JJ, Conget P, Erices A.. Biology and clinical utilization of mesenchymal progenitor cells. Braz. J. Med. Biol. Res. 2000, 33:881-887.
71. Morton KE, Dewhurst CJ. Human amnion in the treatment of vaginal malformations. Br. J. Obstet. Gynaecol. 1986, 93:50-54.
72. Mrugala D, Dossat N, Ringe J, Delorme B, Coffy A, Bony C, Charbord P, Häupl T, Daures J-P, Noël D, Jorgensen C. Gene expression profile of multipotent mesenchymal stromal cells: identification of pathways common to TGFΒ3/BMP2-induced chondrogenesis. Cloning Stem Cells 2009, 11:61-76.
73. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J. Cell Sci. 2000, 113:1161-1166.
74. Nakahara H, Bruder SP, Haynesworth SE, Holecek JJ, Baber MA, Goldberg VM, Caplan AI. Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum. Bone 1990, 11:181-188.
75. Niknejad H, Peirovi H, Jorjani M, Ahmadiani A, Ghanavi J, Seifalian AM. Properties of the amniotic membrane for potential use in tissue engineering. Eur. Cell Mater. 2008, 15:88-99.
76. Parolini O, Alviano F, Bagnara GP, Bilic G, Bühring HJ, Evangelista M, Hennerbichler S, Liu B, Magatti M, Mao N, Miki T, Marongiu F, Nakajima H, Nikaido T, Portmann-Lanz CB, Sankar V, Soncini M, Stadler G, Surbek D, Takahashi TA, Redl H, Sakuragawa N, Wolbank S, Zeisberger S, Zisch A, Strom SC. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells 2008, 26:300-311.
77. Parolini O, Soncini M, Evangelista M, Schmidt D. Amniotic membrane and amniotic fluid-derived cells: potential tools for regeneative medicine?. Regen. Med. 2009, 4:275-291.
78. Parsch D, Fellenberg J, Brummendorf TH, Eschlbeck AM, Richter W. Telomere length and telomerase activity during expansion and differentiation of human mesenchymal stem cells and chondrocytes. J. Mol. Med. 2004, 82:49-55.
79. Pasquinelli G, Tazzari P, Ricci F, Vaselli C, Buzzi M, Conte R. Ultrastructural characteristics of human mesenchymal stromal (stem) cells derived from bone marrow and term placenta. Ultrastruc. Pathol. 2007, 31:23-31.
80. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
81. Pittenger MF. Mesenchymal stem cells from adult bone marrow. Methods Mol. Biol. 2008, 449:27-44.
82. Portmann-Lanz CB, Schoeberlein A, Huber A, Sager R, Malek A, Holzgreve W, Surbek DV. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am. J. Obstet. Gynecol. 2006, 194:664-673.
83. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
84. Resinger C, Vécsei V, Marlovits S. Therapeutic options in the treatment of cartilage defects. Techniques and indications. Radiologe 2004, 44:756-762.
85. Harijadi Rinastiti M, Santoso AL, Sosroseno W Histological evaluation of rabbit gingival wound healing transplanted with human amniotic membrane. Int. J. Oral Maxillofac. Surg. 2006, 35:247-251.
86. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005, 52:2521-2529.
87. Sakuragawa N, Enosawa S, Ishii T, Thangavel R, Tashiro T, Okuyama T, Suzuki S. Human amniotic epithelial cells are promising transgene carriers for allogenic cell transplantation into liver. J. Hum. Genet. 2000, 45:171-176.
88. Sakuragawa N, Kakinuma K, Kikuchi A, Okano H, Uchida S, Kamo I, Kobayashi M, Yokoyama Y. Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J. Neurosci. Res. 2004, 78:208-214. Erratum in: J. Neurosci. Res. 2005; 79, 725.
89. Sakuragawa N, Misawa H, Ohsugi K, Kakishita K, Ishii T, Thangavel R, Tohyama J, Elwan M, Yokoyama Y, Okuda O, Arai H, Ogino I, Sato K. Evidence for active acetylcholine metabolism in human amniotic epithelial cells: applicable to intracerebral allografting for neurologic disease. Neurosci. Lett. 1997, 232:53-56.
90. Samuel GN, Kerridge IH, O'Brien TA. Umbilical cord blood banking: public good or private benefit?. Med. J. Aust. 2008, 188:533-535.
91. Sankar V, Muthusamy R. Role of human amniotic epithelial cell transplantation in spinal cord injury repair research. Neuroscience 2003, 118:11-17.
92. Santos MS, Gomes JAP, Hofling-Lima AL, Rizzo LV, Romano AC, Belfort R Survival analysis of conjuctival limbal grafts and amniotic membrane transplantation in eyes with total limbal stem cell deficiency. Am. J. Ophthalmol. 2005, 140:223-230.
93. Shimmura S, Tsubota K. Ocular surface reconstruction update. Curr. Opin. Ophthalmol. 2002, 13:213-219.
94. Soncini M, Vertua E, Gibelli L, Zorzi F, Denegri M, Albertini A, Wengler GS, Parolini O. Isolation and characterization of mesenchymal cells from human fetal membranes. J. Tissue Eng. Regen. Med. 2007, 1:296-305.
95. Steigman S.A., Fauza D.O. Isolation of mesenchymal stem cells from amniotic fluid and placenta. Curr. Protoc. Stem. Cell. Biol. 2007, ; Chapter 1, Unit 1E.2.
96. Steinert AF, Ghivizzani SC, Rethwilm A, Tuan RS, Evans CH, Nöth U. Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res. Ther. 2007, 9:213.
97. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003, 33:919-926.
98. Takashima S, Ise H, Zhao P, Akaike T, Nikaido T. Human amniotic epithelial cells possses hepatocyte-like characteristics and functions. Cell Struct. Funct. 2004, 29:73-84.
99. Tamagawa T, Ishiwata I, Saito S. Establishment and characterization of a pluripotent stem cell line derived from human amniotic membranes and initiation of germ layers in vitro. Hum. Cell 2004, 17:125-130.
100. Tamagawa T, Oi S, Ishiwata I, Ishikawa H, Nakamura Y. Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro. Hum. Cell 2007, 20:77-84.
101. Tamagawa T., Ishiwata I, Ishikawa H, Nakamura Y. Induced in vitro differentiation of neural-like cells from human amnion-derived fibroblast-like cells. Hum. Cell 2008, 21:38-45.
102. Tanaka M, Chen Z, Bartunkova S, Yamasaki N, Izumo S. The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 1999, 126:1269-1280.
103. Tejwani S, Kolari RS, Sangwan VS, Rao GN. Role of amniotic membrane graft for ocular chemical and thermal injuries. Cornea 2007, 26:21-26.
104. Toda A, Okabe M, Yoshida T, Nikaido T. The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J. Pharmacol. Sci. 2007, 105:215-228.
105. Tritz J, Rahouadi R, de Isla N, Charif N, Pinzano A, Mainard D, Bensoussan D, Netter P, Stoltz J-F, Benkirane -Jessel N, Huselstein C Designing a three-dimensional alginate hydrogel by spraying method for cartilage tissue engineering. Soft Matter 2010, 6:5165-5174.
106. Tsai MS, Hwang SM, Chen KD, Lee YS, Hsu LW, Chang YJ, Wang CN, Peng HH, Chang YL, Chao AS, Chang SD, Lee KD, Wang TH, Wang HS, Soong YK. Functional network analysis on the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 2007, 25:2511-2523.
107. Uchida S, Inanaga Y, Kobayashi M, Hurukawa S, Araie M, Sakuragawa N. Neurotrophic function of conditioned medium from human amniotic epithelial cells. J. Neurosci. Res. 2000, 62:585-590.
108. Villaron EM, Almeida J, Lopez-Holgado N, Alcoceba M, Sánchez-Abarca LI, Sanchez-Guijo FM, Alberca M, Pérez-Simon JA, San Miguel JF, Del Cañizo MC Mesenchymal stem cells are present in peripheral blood and can engraft after allogenic haematopoietic stem cell transplantation. Haematologica 2004, 89:1421-1427.
109. Wakitani S, Kimura T, Hirooka A, Ochi T, Yoneda M, Yasui N, Owaki H, Ono K. Repair of rabbit articular surfaces with allograft chondrocytes embedded in collagen gel. J. Bone Joint Surg. Br. 1989, 71:74-80.
110. Wei JP, Nawata M, Wakitani S, Kametani K, Ota M, Toda A, Konishi I, Ebara S, Nikaido T. Human amniotic mesenchymal cells differentiate into chondrocytes. Cloning Stem Cells 2009, 11:19-25.
111. Wei JP, Zhang TS, Kawa S, Aizawa T, Ota M, Akaike T, Kato K, Konishi I, Nikaido T. Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant. 2003, 12:545-552.
112. Wilshaw SP, Kearney JN, Fisher J, Ingham E. Production of an acellular amniotic membrane matrix for use in tissue engineering. Tissue Eng. 2006, 12:2117-2129.
113. Wolbank S, Peterbauer A, Fahrner M, Hennerbichler S, van Griensven M, Stadler G, Redl H, Gabriel C Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 2007, 13:1173-1183.
114. Wong BJ, Pandhoh N, Truong MT, Diaz S, Chao K, Hou S, Gardiner D. Identification of chondrocyte proliferation following laser irradiation, thermal injury, and mechanical trauma. Lasers Surg. Med. 2005, 37:89-96.
115. Yanada S, Ochi M, Kojima K, Sharman P, Yasunaga Y, Hiyama E. Possibility of selection of chondrogenic progenitor cells by telomere length in FGF-2-expanded mesenchymal stromal cells. Cell Prolif. 2006, 39:575-584.
116. Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM, Johnstone B. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J. Bone Joint Surg. Am. 1998, 80:1745-1757.
117. You Q, Cai L, Zheng J, Tong X, Zhang D, Zhang Y. Isolation of human mesenchymal stem cells from third-trimester amniotic fluid. Int. J. Gynaecol. Obstet. 2008, 103:149-152.
118. Young HE, Steele TA, Bray RA, Hudson J, Floyd JA, Hawkins K, Thomas K, Austin T, Edwards C, Cuzzourt J, Duenzl M, Lucas PA, Black AC Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat. Rec. 2001, 264:51-62.
119. Yuan T, Zhang L, Feng L, Fan H, Zhang X. Chondrogenic differentiation and immunological properties of mesenchymal stem cells in collagen type I hydrogel. Biotechnol. Prog. 2010, July 28 (Epub ahead of print).
120. Zhao P, Ise H, Hongo M, Ota M, Konishi I, Nikaido T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 2005, 79:528-535.
121. Zimmermann S, Voss M, Kaiser S, Kapp U, Waller CF, Martens UM. Lack of telomerase activity in human mesenchymal stem cells. Leukemia 2003, 17:1146-1149.
122. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 2002, 13:4279-4295.
123. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrik MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7:211-228.
124. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, Maini RN. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000, 2:477-488.